Security Snapshot

ACCENDRA HEALTH INC/VA/ - Common Stock (ACH) Institutional Ownership

CUSIP: 690732102

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

138

Shares (Excl. Options)

63,020,101

Price

$2.28

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
-6,076,591
Value change
-$15,906,031
Number of holders
138
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
76,424,795
SEC-reported price per share
$3.71
Insider filing price
$3.71
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • ACH - ACCENDRA HEALTH INC/VA/ - Common Stock is tracked under CUSIP 690732102.
  • 138 institutions reported positions in Q1 2026.
  • 5 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 164 to 138 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $193,142,797 to $143,788,820.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 138 institutions filings for Q1 2026.

Open SEC evidence

Security key

690732102

Latest holder period

Q1 2026

13F holders

138

13D/G owners

5

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
5
Security
ACH
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Coliseum Capital Management, LLC 17% +12% $62,883,874 +$7,381,690 13,100,807 +13% Coliseum Capital Management, LLC 12 Nov 2025
BlackRock, Inc. 7.1% -51% $29,888,199 -$32,238,791 5,454,051 -52% BlackRock, Inc. 30 Sep 2025
Webb Kevin Michael 5.6% $10,375,583 4,287,431 Kevin M. Webb 12 Mar 2026
DIMENSIONAL FUND ADVISORS LP 4.5% $16,836,283 3,507,559 Dimensional Fund Advisors LP 30 Sep 2025
FMR LLC 3.5% -50% $18,895,342 -$21,453,010 2,718,754 -53% FMR LLC 31 Mar 2025

As of 31 Mar 2026, 138 institutional investors reported holding 63,020,101 shares of ACCENDRA HEALTH INC/VA/ - Common Stock (ACH). This represents 82% of the company’s total 76,424,795 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
75%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Coliseum Capital Management, LLC 17% 13,100,807 0% 2.4% $29,869,840
BlackRock, Inc. 6.9% 5,235,300 -3.3% 0% $11,936,485
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 4.8% 3,635,526 -10% 0% $8,288,999
BANK OF AMERICA CORP /DE/ 4.5% 3,407,075 +107% 0% $7,768,130
Invenomic Capital Management LP 4.4% 3,368,975 -3.8% 0.35% $7,681,263
D. E. Shaw & Co., Inc. 4.3% 3,311,601 -6.9% 0.01% $7,550,451
VANGUARD CAPITAL MANAGEMENT LLC 4.3% 3,282,174 0% 0% $7,483,357
VANGUARD PORTFOLIO MANAGEMENT LLC 3.5% 2,651,152 0% 0% $6,044,627
DIMENSIONAL FUND ADVISORS LP 3.4% 2,606,620 -13% 0% $5,943,093
GEODE CAPITAL MANAGEMENT, LLC 2.4% 1,835,910 +3.7% 0% $4,187,101
PARADIGM CAPITAL MANAGEMENT INC/NY 2.3% 1,786,400 +5.9% 0.16% $4,072,992
MARSHALL WACE, LLP 2.3% 1,761,004 +230% 0% $4,015,090
STATE STREET CORP 2.1% 1,629,956 +1.8% 0% $3,716,300
Dana Investment Advisors, Inc. 1.9% 1,485,097 -0.23% 0.1% $3,386,021
Connor, Clark & Lunn Investment Management Ltd. 1.8% 1,380,728 +7.8% 0.01% $3,148,060
TWO SIGMA INVESTMENTS, LP 1.6% 1,201,269 +1.7% 0% $2,738,893
GOLDMAN SACHS GROUP INC 1.2% 941,173 +41% 0% $2,145,874
ACADIAN ASSET MANAGEMENT LLC 1.2% 907,096 +25% 0% $2,060,000
AQR CAPITAL MANAGEMENT LLC 0.96% 732,221 +53% 0% $1,669,464
WOLVERINE ASSET MANAGEMENT LLC 0.91% 695,415 +99% 0.02% $1,585,546
NORTHERN TRUST CORP 0.79% 600,961 +3.5% 0% $1,370,192
MILLENNIUM MANAGEMENT LLC 0.62% 474,788 -82% 0% $1,082,517
VANGUARD FIDUCIARY TRUST CO 0.61% 468,097 0% 0% $1,067,261
MORGAN STANLEY 0.56% 424,778 -44% 0% $968,496
Vanguard Global Advisers, LLC 0.55% 422,674 0% 0% $963,697

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
49
Latest
Q1 2026
Rows shown
1-25 of 49
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 63,020,101 $143,788,820 -$15,906,031 $2.28 138
2025 Q4 69,010,661 $193,142,797 -$21,055,718 $2.80 164
2025 Q3 72,665,540 $348,919,613 -$36,147,032 $4.80 199
2025 Q2 74,911,735 $681,592,001 +$6,808,279 $9.10 231
2025 Q1 74,234,901 $669,904,220 -$41,361,744 $9.03 242
2024 Q4 75,999,880 $993,408,211 -$22,298,063 $13.07 196
2024 Q3 76,641,615 $1,202,263,604 +$5,538,488 $15.69 212
2024 Q2 77,392,783 $1,044,984,551 -$24,988,928 $13.50 219
2024 Q1 77,756,673 $2,154,498,690 +$31,589,711 $27.71 222
2023 Q4 77,989,310 $1,502,830,727 -$61,472,120 $19.27 225
2023 Q3 81,203,106 $1,312,296,789 +$96,186,745 $16.16 207
2023 Q2 75,096,359 $1,429,920,834 +$18,180,780 $19.04 224
2023 Q1 74,092,292 $1,077,976,874 -$30,742,475 $14.55 212
2022 Q4 75,706,168 $1,478,583,202 -$46,627,129 $19.53 214
2022 Q3 77,024,935 $1,855,979,184 -$50,565,219 $24.10 211
2022 Q2 78,514,995 $2,469,843,426 +$44,857,192 $31.45 240
2022 Q1 77,065,981 $3,392,912,828 +$215,548,902 $44.02 256
2021 Q4 72,003,396 $3,132,242,501 -$84,625,972 $43.50 262
2021 Q3 71,397,192 $2,234,559,466 +$52,528,014 $31.29 236
2021 Q2 68,913,037 $2,916,387,652 +$142,167,170 $42.33 256
2021 Q1 65,692,101 $2,469,466,454 +$51,163,110 $37.59 250
2020 Q4 64,815,224 $1,753,331,583 +$280,313,743 $27.05 226
2020 Q3 54,517,376 $1,364,451,183 -$17,454,505 $25.11 200
2020 Q2 56,156,110 $427,824,951 +$6,008,485 $7.62 180
2020 Q1 55,013,251 $503,242,182 -$1,599,130 $9.15 173
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .